AstraZeneca plans $1.5B manufacturing site

The latest stories trending on MedCity News.

Editor's Pick

Top Story AstraZeneca Plans $1.5B Manufacturing Site for Global Production of ADC Cancer Drugs The Singapore manufacturing site will be AstraZeneca's first facility capable of handling all steps of antibody drug conjugate production. AstraZeneca aims to open the facility in 2029.

Featured News

Importance of Patient Capital in Life Sciences The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development. Centivo Acquires a Primary Care Startup, Despite Others Fleeing the Space Centivo, a health plan that sells to self-funded employers, acquired virtual-first primary care startup Eden Health. With this acquisition, Centivo now serves more than 160 employers in all 50 states. Nutrition Counseling Startup Emerges from Stealth with $25M Fay emerged from stealth with $25 million in funding. The company connects patients to a network of registered dietitians. Tax Challenges for Healthcare Accounting Teams Bring Opportunity for Innovation A good outsourced partner can work alongside in-house accountants and stay on top of the moving target of healthcare accounting regulations, addressing tax risks and identifying cost-saving opportunities.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Adaeze Enekwechi, CEO of Cayaba Care In this month's episode, Senior Reporter Katie Adams explored some executive hires and exits that recently occurred in the healthcare world, as well as layoffs affecting the industry. She also interviewed Adaeze Enekwechi, who became CEO of Cayaba Care this month. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe